Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT07195071
- Status
- Recruiting
Conditions
- Hereditary Cancer Syndrome
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- Natera empower comprehensive hereditary cancer panel — DEVICENatera Empower Comprehensive Hereditary Cancer Panel to screen for hereditary cancers
- Obstetrical carrier screening — DEVICEObstetrical carrier screening for genetic conditions
Study Details
The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention
Key Dates
- Start date
- Feb 12, 2026
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Experimental: Arm A: Hereditary cancer testingHereditary Cancer screenings testing and Obstetric Cancer Screening
- Active Comparator: Arm B: No hereditary caner testingObstetric Cancer screening test only
Primary Outcome Measure
Percentage of Participants Who Complete Both HCS and OCS [ Time Frame: Approximately at the end of recruitment, expected at 2 years ]
Central Contacts
- Jessica Giordano212-305-7250
- Reena Vattakalam212-342-6895
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10032 | Shayan Dioun, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By research site
Related Studies
- Chatbot to Maximize Hereditary Cancer Genetic Risk AssessmentRecruiting · Weill Medical College of Cornell University · Brooklyn, New York
- Li-Fraumeni & TP53 (LiFT UP): Understanding and ProgressRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)Recruiting · University of Illinois at Chicago · Chicago, Illinois
- Lynch Syndrome X-Talk of Enteral Mucosa With Immune SystemRecruiting · San Raffaele University · Monrovia, California